<div class="headers"><div>Figure 1—Effects on efﬁcacy parametersC: Change from baseline in HbA1c in subgroups with baseline HbA1c ,9.0% (,75 mmol/mol) or $9.0% ($75 mmol/mol) at week 26</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>1(A)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='text-align: left;'>1</td>
<td style='text-align: left;'>1</td>
<td style='text-align: left;'><p style="" class="">Figure 1—Effects on efﬁcacy parameters</p></td>
</tr>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>2</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>2</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p style="" class="">C: Change from baseline in HbA1c in subgroups with baseline HbA1c ,9.0% (,75 mmol/mol) or $9.0% ($75 mmol/mol) at week 26</p></td>
</tr>
</tbody>
</table>
